相似化合物
30384-96-4 372198-69-1 474708-98-0欧盟法规
ECHA物质C&L通报上下游产品
CAS号372198-69-1 6-溴咪唑并[1,2-a]吡啶... | CAS号1072-97-5 2-氨基-5-溴吡啶合成工艺路线路线简述
- 合成目标产物 6-Bromoimidazo[1,2-A]Pyridine-3-Carboxylicacid 主要起始原料 Imidazo[1,2-A]Pyridine-3-Carboxylic Acid, 6-Bromo-, Ethyl Ester
- 372198-69-1 = 944896-42-8
反应条件:1.1 Reagents: Lithium Hydroxide Solvents: Methanol,Water; 2 H,20 °C1.2 Reagents: Hydrochloric Acid Solvents: Water; Ph 5
标题:Method For Synthesis Of 6-Bromoimidazo[1,2-A]Pyridine-3-Carboxylic Acid
参考文献:China]
372198-69-1 = 944896-42-8
反应条件:1.1 Reagents: Lithium Hydroxide Solvents: Methanol,Tetrahydrofuran,Water; 1 H,Rt1.2 Reagents: Hydrochloric Acid Solvents: Water; Ph 1 - 2
标题:Preparation Of Benzo-Heterocycles Compound As Pi3K Alpha Kinase Inhibitor
参考文献:China]
372198-69-1 = 944896-42-8
反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Ethanol,Water; 24 H,50 °C
标题:Combination Of Kinase Inhibitors And Uses Thereof
参考文献:United States]
372198-69-1 = 944896-42-8
反应条件:1.1 Reagents: Lithium Hydroxide Solvents: Ethanol,Tetrahydrofuran; 3 D,Rt1.2 Reagents: Hydrogen Ion Solvents: Water; Neutralized
标题:Preparation Of Substituted N-(1H-Indazol-4-Yl)Imidazo[1,2-A]Pyridine-3-Carboxamide Compounds As Type Iii Receptor Tyrosine Kinase Inhibitors
参考文献:World Intellectual Property Organization]
1072-97-5 + 33142-21-1 = 944896-42-8
反应条件:1.1 Solvents: Ethanol; Rt -> 78 °C; 1 - 2 D,78 °C; 78 °C -> Rt1.2 Reagents: Sodium Hydroxide Solvents: Water; 30 Min,< 35 °C; 3 - 4 H,35 °C -> 78 °C1.3 Reagents: Hydrochloric Acid Solvents: Water; 1 - 2 H,Ph 1 - 2,0 - 5 °C
标题:(1Ar,12Bs)-8-Cyclohexyl-11-Fluoro-N-((1-Methylcyclopropyl)Sulfonyl)-1A-((3-Methyl-3,8-Diazabicyclo[3.2.1]Oct-8-Yl)Carbonyl)-1,1A,2,2B-Tetrahydrocyclopropa[d]Indolo[2,1-A][2]Benzazepine-5-Carboxamide For Use In Treating Hcv
参考文献:European Patent Organization]
1072-97-5 + 33142-21-1 = 944896-42-8
反应条件:1.1 Solvents: Ethanol; 1 - 2 D,Rt -> 78 °C; 78 °C -> Rt1.2 Reagents: Sodium Hydroxide Solvents: Water; 30 Min,< 35 °C; 3 - 4 H,35 °C -> 78 °C1.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 1 - 2,0 - 5 °C; 1 - 2 H,0 - 5 °C
标题:Preparation Of Polymorphs Of Kinase Inhibitor [6-(2-Aminobenzo[d]Oxazol-5-Yl)Imidazo[1,2-A]Pyridin-3-Yl](Morpholino)Methanone
参考文献:World Intellectual Property Organization]
372198-69-1 = 944896-42-8
反应条件:1.1 Reagents: Lithium Hydroxide Solvents: Methanol,Tetrahydrofuran,Water; 60 °C1.2 Reagents: Hydrochloric Acid Solvents: Water; Acidified
标题:Discovery Of 3,6-Disubstituted-Imidazo[1,2-A]Pyridine Derivatives As A New Class Of Clk1 Inhibitors
作者:Zhang,Yun; Xia,Anjie; Zhang,Shiyu; Lin,Guifeng; Liu,Jingming; Et Al
参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2021 卷标:41]
372198-69-1 = 944896-42-8
反应条件:1.1 Reagents: Lithium Hydroxide Solvents: Methanol,Tetrahydrofuran,Water; Overnight,60 °C1.2 Reagents: Hydrochloric Acid Solvents: Water; Ph 4
标题:Bicyclic Heteroaryls As Kinase Inhibitors And Their Preparation
参考文献:World Intellectual Property Organization]
474708-98-0 = 944896-42-8
反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Ethanol,Water; 12 H,100 °C; Cooled1.2 Reagents: Hydrochloric Acid Solvents: Water; Ph 4,Cooled
标题:2,3-Disubstituted Pyridine Compounds As Tgf-Beta Inhibitors And Their Preparation
参考文献:World Intellectual Property Organization
5-溴-2-吡啶-N,N-二甲基甲眯置于lithium Hydroxide Monohydrate,水,碳酸氢钠体系中,用 四氢呋喃,甲醇,异丙醇 作为反应溶剂,化学反应 12.0H,反应生成 6-溴咪唑并[1,2-A]吡啶-3-羧酸
参考文献: 2,3-Disubstituted Pyridine Compounds As Tgf-Beta Inhibitors And Methods Of Use[fr] Composés De Pyridine 2,3-Disubstitués Utilisés Comme Inhibiteurs De Tgf-Bêta Et Procédés D'Utilisation
标题: 2,3-Disubstituted Pyridine Compounds As Tgf-Beta Inhibitors And Methods Of Use[fr] Composés De Pyridine 2,3-Disubstitués Utilisés Comme Inhibiteurs De Tgf-Bêta Et Procédés D'Utilisation
摘要:本发明涉及的化合物包括公式(iv)的化合物,以及一种治疗癌症的方法,包括向患有癌症的受试者施用其中一种化合物,结合另一种癌症治疗方法.这些化合物(iv)抑制tgf-β超家族成员如nodal或activin的信号传导.
海关参考信息
- 2905110000-甲醇
2912110000-甲醛
2915110000-甲酸
2933310010-吡啶 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:WO-2011050245-A1
优先权日:2009-10-23
标 题:Bicyclic heteroaryls as kinase inhibitors
发明人:FENG YANGBO; CHEN YEN TING; SESSIONS HAMPTON; MISHRA JITENDRA K; CHOWDHURY SARWAT; YIN YAN; LOGRASSO PHILIP; LUO JUN-LI; BANNISTER THOMAS; SCHROETER THOMAS
权利人:FENG YANGBO; CHEN YEN TING; SESSIONS HAMPTON; MISHRA JITENDRA K; CHOWDHURY SARWAT; YIN YAN; LOGRASSO PHILIP; LUO JUN-LI; BANNISTER THOMAS; SCHROETER THOMAS
摘要:The invention is directed to heteroaryl compounds useful as inhibitors of various kinase enzymes. In various embodiments, the invention provides a heteroaryl compound having inhibitory bioactivity with respect to a Rho kinase, an AKT kinase, a p70S6K kinase, a LIM kinase, an IKK kinase, a Flt kinase, an Aurora kinase, or a Src kinase, or any combination thereof. Compounds of the invention include bicyclic heteroaryl compounds of formula (I), which can contain a bridging nitrogen atom at a ring junction. The invention further provides methods of synthesis of compounds of the invention, pharmaceutical compositions, pharmaceutical combinations, and methods of treatment of malconditions using compounds of the invention.